Uterine fibroids are some of the most common tumours of females, but relatively little is known about their molecular basis. Several studies have suggested that deletions on chromosome 7q could have a role in fibroid formation. We analysed 165 sporadic uterine fibroids to define a small 3.2 megabase (Mb) commonly deleted region on 7q22.3-q31.1, flanked by clones AC005070 and AC007567. We also used oligonucleotide microarrays to compare the expression profiles of 10 samples of normal myometrium and 15 fibroids, nine of which displayed 7q-deletions. Activating transcription factor 3, patched homolog (Drosophila), homeo box A5, death-associated protein kinase 1, and retinoic acid receptor responder 3 were downregulated, and excision repair crosscomplementing 3, transcription factor AP-2 gamma and protein kinase C beta 1 were upregulated in fibroids. New pathways were discovered related to fibroid formation. The presence or absence of 7q-deletions did not dramatically affect the global expression pattern of the tumours; changes, however, were observed in genes related to vesicular transport and nucleic acid binding.
Introduction
Uterine fibroids or leiomyomas are benign tumours arising from the smooth muscle lining of the uterus, the myometrium. They are the most common tumours in women of reproductive age and clinically apparent in at least 25% of females, but some estimates suggest that the proportion of affected individuals might be as high as 77% (Stewart, 2001) . Although fibroids are benign, they are a common cause of severe morbidity in the form of abnormal bleeding, pelvic pain or discomfort and reproductive dysfunction. Fibroids are the single most common cause for hysterectomy, which also make them a significant cost for the health care system (Ligon and Morton, 2000; Stewart, 2001) .
Even though fibroids are very common, not much is known about their genetic background. Cytogenetic studies have detected chromosomal abnormalities in about 30-50% of fibroids (Pandis et al., 1991; Rein et al., 1991; Vanni et al., 1991) . The most common alterations have been deletions on chromosome 7q21-q31, and other abnormalities have involved chromosomes 6, 12 and 14 (Nibert and Heim, 1990 ). In addition, several allelotyping studies of uterine fibroids have discovered deletions on chromosome 7q21-q31 (Ishwad et al., 1995 (Ishwad et al., , 1997 van der Heijden et al., 1998; Mao et al., 1999) . All these studies consistently point to a common deleted region around markers D7S518 and D7S471, which according to Knudson's two-hit model suggests a leiomyoma suppressor gene in that region. Tumour-specific point mutations in sporadic fibroids have been discovered in only two genes: fumarate hydratase (FH), a gene coding the enzyme catalysing the hydration of fumarate to malate in the tricarboxylic acid cycle (Krebs cycle), and K-RAS (Hall et al., 1997; Lehtonen et al., 2004) .
DNA microarray analysis has been proven to serve as a useful tool in studying global gene expression in human tumours, and a number of studies have already investigated differences in gene expression levels between normal myometrium and uterine fibroids (Tsibris et al., 2002; Wang et al., 2003; Weston et al., 2003) . There are clear differences between the results produced by different microarray experiments on fibroids, although some genes, such as actin binding LIM protein 1, collagen type IV alpha 2, early growth response 1, GATA-binding protein 2, endothelin receptor type A, and c-jun, have been detected as differentially expressed in several studies. The variation in the results is likely due to different microarray techniques used, as well as to differences in data analysis methods (Hoffman et al., 2004) . The small number of samples in some of the studies has also compromised the statistical power to identify differentially expressed genes. In addition, none of the previous studies has taken into account different genetic statuses of the investigated tumours, a factor which is likely to affect their gene expression levels. We have used deletion mapping to further characterize the commonly deleted 7q region in uterine fibroids and to classify samples for expression microarray experiments. Assuming that biologically different tumours also have significantly different mRNA expression profiles we used oligonucleotide microarrays to test whether 7q-deletions define a distinct subgroup of fibroids. In addition, to further characterize the gene expression pattern in uterine fibroids, we compared fibroid gene expression profiles to those of normal myometrium.
Results

Fibroid histology
Frozen sections from the samples subjected to microarray experiments were stained with HE, and sample histology was confirmed. All fibroids were defined as typical leiomyomas.
LOH mapping
With 25 polymorphic microsatellite markers covering about 20 Mb on chromosome 7q21-q31, 11 fibroids out of 165 (6.7%) showed loss of heterozygosity (LOH) at least with two markers. These fibroids were from eight different patients, that is three patients had two individual tumours that showed LOH on 7q (Figure 1 ). Although three tumours did not meet the criteria for LOH with all markers in the common region of allelic imbalance (AI), true retention of heterozygosity and thus the possibility of a homozygous deletion was ruled out by a clear trend towards LOH seen in the allele intensity curves. The analysis defined a smallest common region of AI in 7q22.3-q31.1, flanked by markers 7qAC005070 on the centromere side and 7qAC007567 on the telomere side. The results are compatible with a deletion of 3.2 mega bases. It covers at least 22 different transcripts, 20 of which are represented on the HG-U133A chip by 31 different probes (Table 1) .
Microarray comparative genomic hybridization (CGH)
Tumours showing LOH on chromosome 7 were further analysed using microarray CGH to confirm that the AI observed using microsatellite markers arises from deletions rather than amplifications. Of 10 samples analysed, eight showed deletion in the region predicted by LOH, while two samples, 34 and 51 m1, showed no deletion. One of the samples showing no predicted loss (51 M1) demonstrated whole chromosome gains of chromosomes 8, 9, 12, 14, and 19. These chromosomal alterations were unique to this sample. Homozygous deletions were not observed in any of the samples.
Gene expression analysis
A total of 25 samples from 11 patients were successfully hybridized on expression microarray chips. There were 10 samples of normal myometrium (N), and the 15 Figure 1 Deletion map of chromosome 7q. NI, noninformative; ND, no data; LOH, loss of heterozygosity; LOH(?), marginal loss of heterozygosity; dash (À), heterozygosity. Scoring of LOH, see Materials and methods. Sample names are shown in the top bar; the first number refers to the patient. Note that patients 9, 14, and 38 had two individual fibroids with a deletion. In the deletion matrix, the darkest grey shaded area highlights a deletion and the lightest grey normal heterozygosity in individual samples. The medium grey shaded colour shows the 3.2 Mb commonly deleted region found in our study. The black double-headed arrow indicates the 5.3 Mb commonly deleted region based on previous reports. The smaller double-headed arrow indicates the 2.3 Mb commonly deleted region based on previous studies combined with new data 7q deletion mapping and expression profiling in fibroids S Vanharanta et al tumour samples consisted of two different subgroups: nine fibroids with deletions on chromosome 7q (7QD) and six fibroids without a 7q-deletion (N7Q). An unsupervised hierarchical cluster tree ( Figure 2 ) with all 25 samples was constructed as described in Materials and methods. With the 1057 most differentially expressed probes across the arrays, the samples were divided into two major branches, one mainly consisting of normal myometrium and one of fibroid samples. Tumours with 7q-deletions were not clearly separated from the group N7Q.
Normal myometrium compared to fibroids
To find differentially expressed genes we first compared normal myometrium to all fibroids as one group (7QD þ N7Q). Allowing a false discovery rate of 5% we identified 133 differentially expressed sequences, 54 being upregulated (Table 2 ) and 79 downregulated (Table 3) in fibroids compared to adjacent myometrium. These corresponded to at least 111 different genes as 10 genes were represented by more than one probe set. Different probe sets of each gene showed markedly consistent fold changes, for example, fibronectin 1 was represented by four probes, the fold changes of which between the myometrium and fibroids ranged from 1.72 to 1.79. Other examples were tenascin XB with four probes (fold changes from 0.42 to 0.49), and nuclear factor I/B with three probes (fold changes from 0.59 to 0.63).
The most upregulated genes in fibroids were proteolipid protein 1 (PLP1) and excision repair crosscomplementing 3 (ERCC3). They were the only genes that had a fold change greater than 3. On the other hand, the most down-regulated genes in fibroids were activating transcription factor 3 (ATF3), patched homolog (PTCH), and baculoviral IAP repeat-containing 3 (BIRC3) with fold changes 0.20, 0.28, and 0.32, respectively. Other downregulated genes were, for example, growth arrest and DNA-damage-inducible beta (GADD45B), retinoic acid receptor responder 3 (RARRES3), homeo box A5 (HOXA5), B-cell CLL/lymphoma 6 (BCL6), and deathassociated protein kinase 1 (DAPK1). Interesting upregulated genes in fibroids were cyclin D1 (CCND1), phosphodiesterase 8B (PDE8B), transcription factor AP-2 gamma (TFAP2C), and protein kinase C beta 1 (PRKCB1). The differential expression of two genes were further studied with real-time quantitative polymerase chain reaction (PCR); both DAPK1 and RARRES3 showed significant downregulation with P-values of 0.019 and 0.038, respectively, thus confirming expression microarray results. Differentially expressed genes were grouped into biologically meaningful categories according to Gene Ontology (GO) information (Ashburner et al., 2000) . Of the 111 genes 87 had at least one GO annotation, and they belonged to 515 categories. A functional group enrichment test showed that 40 of the ontology terms represented by more than two genes were enriched with differentially expressed genes (Supplementary Table 1 ). Among these, however, were several overlapping or nearly identical categories and thus the true number of differentially expressed functional groups was substantially lower. For example, transcription-related genes, 13 of which were downregulated (ATF3, BCL6, CITED2, EGR1, GATA2, HOXA5, JUN, KLF2, KLF4, MSX1, NFIB, NR3C1, NR4A2) and four upregulated in fibroids (SATB2, SOX4, TFAP2C, TRPS1) were represented in several categories such as Transcription Factor Activity (GO: 0003700), Transcription (GO: 0006350), Transcription Regulator Activity (GO: 0030528), and DNA Binding (GO: 0003677). Additional categories significantly enriched with genes differentially expressed were Response to Stress (GO: 0006950) with 13 genes, three of which were upregulated (DDB2, ERCC3, FN1) and eight downregulated (APOL3, BCL6, C1R, C1S, GADD45B, MAP3K5, NR3C1, NR4A2, PDLIM1, SMAD7) and Extracellular Matrix (GO: 0005578) with nine genes upregulated (COL1A1, COL3A1, COL4A1, COL4A2, COL5A2, COL9A2, LTBP2, MFAP2, MMP11) and two downregulated (LTBP1, TNXB) in fibroids.
Fibroids with 7q-deletions compared to fibroids without deletions
We next compared the expression profiles of 7QD and N7Q fibroids. As the cluster analysis shown in Figure 2 suggested, no gross differences were observed at the level of overall expression profile. At the level of individual genes this was reflected by the fact that the smallest median false discovery rate obtained after permutations was estimated to be >50%. To identify the genes most likely to be differentially expressed between the two groups, we used a two-sided heteroscedastic t-test for sorting the probes according to unadjusted P-values; the 107 probes with a P-value smaller than 0.01 are listed in Supplementary Table 2. Only two of the genes, CAV2 and CAPZA2, are located on the long arm of chromosome 7, but neither of them falls into the small commonly deleted region. We grouped the genes into functional categories and found 22 GO categories enriched with more than two genes differentially expressed (Supplementary Table 3 ). The most clearly enriched were Nuclear Membrane (GO: 0005635), ER to Golgi Transport (GO: 0006888), Endomembrane System (GO: 0012505), and Nucleic Acid Binding (GO: 0003676). As seen in the normal-to-fibroid comparison, several categories were closely related and thus the real number of functionally enriched groups was smaller than 22.
When looking specifically at the expression of the probes located on the commonly deleted region in 7q, no single candidate tumour suppressor could be identified. The 31 probes represented 20 of the 22 different transcripts in the region, and thus two transcripts were not represented on the chips used. Also, six probes were called absent in all 25 samples, two probes were present only in one sample and one probe only in two samples. In addition, one of the probes representing PP35 was detected in five normal samples but only in three tumours. This left 13 transcripts out of 22 that were consistently expressed at detectable levels. As Table 1 shows, most of the probes in the deleted region had lower expression in 7QD fibroids relative to N7Q, although only two of them had a P-value smaller than 0.05: component of oligomeric golgi complex 5 (COG5, P ¼ 0.02) and Rad50-interacting protein 1 (RINT-1, Figure 2 Unsupervised hierarchical cluster tree of all 25 samples. Blue, purple and yellow bars indicate samples of normal myometrium, fibroids with 7q deletions and fibroids without a deletion, respectively. Relative increased and decreased expression of 1057 most differentially expressed genes across the samples is depicted in red and green, respectively. The sample names are shown below the tree 7q deletion mapping and expression profiling in fibroids S Vanharanta et al P ¼ 0.04). COG5, however, had also another probe that did not show as clear a downregulation. The expression of RINT-1 was further studied by quantitative real-time PCR, but no significant deregulation was detected (P ¼ 0.75).
Discussion
In this study we have used deletion mapping of chromosome 7q to identify a small commonly deleted region in uterine fibroids. In addition, we investigated the effects of such deletions on the expression profiles of these tumours. Several reports have proposed a role for the 7q-deletions in leiomyoma formation (Ligon and Morton, 2000) , but this is the first time their effects have been studied on a transcriptome-wide level. Also, we have evaluated the changes in expression profiles between fibroids and the adjacent myometrium. Although this has been investigated before, the small number of samples has clearly compromised the power of the previous The smallest commonly deleted region defined by LOH analysis was delimited by markers 7qAC005070 and 7qAC007567, a region of 3.2 Mb. Further analysis with microarray CGH confirmed that most of the changes were indeed deletions, not amplifications, but no homozygous deletions were observed. Also, the lack of chromosomal deletions in two tumours showing LOH indicates that mitotic recombination, rather than deletion, may be the cause of LOH in some fibroids (Gupta et al., 1997; Blackburn et al., 2004) . Since the previous deletion mapping efforts on fibroids were conducted before the final version of the human genetic map was available, some of the marker information has changed (Ishwad et al., 1995 (Ishwad et al., , 1997 van der Heijden et al., 1998; Mao et al., 1999) . In particular, the results by van der Heijden et al. rely critically on marker D7S501, the published reverse primer of which does not have a perfect match on the 7q22.3 target region in the latest version (v29.35b) of Ensembl (www.ensembl.org) genome browser, thus making the assessment of LOH in our experience nonreproducible (data not shown). When this and the possibility of a small homozygous deletion as the explanation for retention of heterozygosity (Cairns et al., 1994; Ishwad et al., 1997) are taken into account, the former smallest commonly deleted region was 5.3 Mb and flanked by markers D7S518 and D7S496. Our data further reduces the commonly deleted region to be flanked by markers 7qAC005070 and D7S496, a region of only 2.3 Mb.
Microarray analyses revealed several genes that to our knowledge have not been previously reported as deregulated in fibroids; for example, ERCC3, TFAP2C, and PRKCB1 were upregulated, and PTCH, GADD45B, HOXA5, DAPK1, and RARRES3 were downregulated in fibroids. To test the reproducibility of the results with another method, we analysed DAPK1 and RARRES3 expression with quantitative real-time PCR; in both cases the expression microarray results were strongly supported. We also observed some changes that contradicted previous results. For example fibronectin 1, which in our study was significantly upregulated in fibroids with four independent probe sets, has been reported as downregulated in fibroids in a microarray study containing only six fibroid samples (Chegini et al., 2003) . The changes in the expression profiles observed between normal myometrium and fibroid tissue also confirmed some previously reported results (Kovacs et al., 2001; Tsibris et al., 2002; Ahn et al., 2003; Chegini et al., 2003; Wang et al., 2003; Weston et al., 2003) . For example, CCND1, endothelin receptor type A (EDNRA), collagen type III alpha 1 (COL3A1), and collagen type IV alpha 2 (COL4A2) were upregulated, and early growth response 1 (EGR1), complement component 1r (C1R), actin binding LIM protein 1 (ABLIM1), v-jun sarcoma virus 17 oncogene homolog (JUN), and B-cell CLL/lymphoma 6 (BCL6) were downregulated in fibroids.
Although definitive conclusions regarding the role of the differentially expressed genes in tumorigenesis are very difficult to make, based on the current literature it is tempting to hypothesize that some of them could be directly involved in fibroid formation and growth. For example, death-associated protein kinase 1 (DAPK1) is a serine/threonine kinase that is associated with the cytoskeleton, and its expression is reduced in several types of human cancer, mainly due to promoter hypermethylation. This kinase mediates cell death in response to various stimuli such as TNF-a, TGF-b and detachment from the extracellular matrix (Gozuacik and Kimchi, 2004) . One study showed that DAP kinase activates a p19ARF/p53-dependent apoptotic checkpoint and thus counteracts oncogene-induced transformation (Raveh et al., 2001) . In this study, we have detected reduced DAPK1 expression in fibroids, which could facilitate fibroid cells to avoid cell death and thus promote tumour growth. Another interesting gene downregulated in fibroids was RARRES3. It is a tumour suppressor candidate and it mediates growth suppressive effects of retinoids (DiSepio et al., 1998) . Notably, also other genes involved in the effects of retionoids were downregulated in fibroids, for example, retinoic acid receptor responder 2 (RARRES2) and retinol binding protein 1 (RBP1). To further understand the biological meaning of the differentially expressed genes at the level of functional categories, a functional group enrichment test was implemented. It revealed that genes related to extracellular matrix, transcription, and cellular stress responses were deregulated in fibroids. Collagen has been shown to directly stimulate smooth muscle cell growth (Herz et al., 2003) and regulate cell migration (Parameswaran et al., 2004) . Increased expression of collagens and other extracellular matrix proteins could thus have an important role in fibroid growth. Of the 13 differentially expressed genes related to stress responses, only three were upregulated in fibroids. Two of them, DDB2 and ERCC3, are both involved in nucleotide excision repair (Itoh et al., 2004; Terashita et al., 2004) .
Previously, it has been shown that commonly deleted genomic regions in tumours can harbour tumour suppressor genes (Li et al., 1997) . Also, it has been shown, that mutations of a single tumour suppressor gene can significantly alter the global expression pattern of a tumour (Mori et al., 2003) . We hypothesized that fibroids with deletions on 7q form a distinct subgroup of fibroids due to the loss of a putative tumour suppressor gene on 7q, and this would be reflected in the global gene expression profile of the respective fibroids. However, when comparing the gene expression of nine tumours with 7q deletions to six tumours without deletions, a method based on false discovery rate estimation (Tusher et al., 2001 ) did not find differentially expressed genes with an acceptable confidence. To reduce the stringency of the correction for multiple tests, an unadjusted t-test was used, and this detected 107 sequences differentially expressed with a P-value smaller than 0.01. Among these there were two genes that map to chromosome 7q, although neither of them locates in the small commonly deleted region. A more specific look at the genes in the deleted region revealed that most of the probes were indeed downregulated in fibroids with 7q-deletions, although only two, RINT-1 and COG5, had P-values smaller than 0.05. Neither of these, however, qualified as a differentially expressed gene when corrected for the estimated rate of false discoveries, and in accordance with this, no downregulation of RINT-1 was observed in further studies with quantitative real-time PCR. Thus our analysis could not unequivocally identify a single candidate tumour suppressor gene in the commonly deleted region on 7q.
These results suggest that N7Q and 7QD fibroids are biologically relatively similar. It is possible that the deletions interfere with a genetic pathway that is altered in the rest of fibroids through a different mechanism, for example, promoter hypermethylation of the putative leiomyoma suppressor on 7q, and this could obscure the differences between the two groups of fibroids. Furthermore, different deletions could target different leiomyoma suppressor genes, or the suppressor could be haploinsufficient, which would greatly complicate the identification of the gene. Yet another possibility is that the tumour suppressor is an RNA gene that does not code proteins (Palatnik et al., 2003) , which also would make the identification of the tumour suppressor more difficult. It is also possible that the deletions do not have a biologically significant role in fibroid formation. This explanation, however, does not appear appealing, since the deletions have been independently reported to map into a consistent region on 7q21-q31. In addition, only 13 of the 22 commonly deleted transcripts were consistently expressed at detectable levels in our microarray experiment. This leaves 10 additional candidate genes that could be downregulated in fibroids with 7q-deletions, but that would have escaped our analyses. Although many of these are relatively poorly characterized, for example FLJ23834 (NM_152750) is an interesting candidate as it contains cadherin domains and is homologous to Drosophila fat tumour suppressor.
In conclusion, our results presented in this report suggest that 7q-deletions do not substantially modify the global gene expression profiles in uterine fibroids, although it still remains possible that the deletions have an important role in their pathogenesis. Our mapping effort further reduced the commonly deleted region on chromosome 7q22-q31 to only 2.3 Mb, and the expression microarray analysis gave novel information regarding the changes in global gene expression pattern caused by the deletions. This will be valuable when further experiments are conducted to test whether one or several of the deleted genes truly act as a tumour suppressor. In addition, significant biological insight was gained from the identification of multiple differentially expressed genes between fibroids and normal myometrium for the first time. These results suggest new pathways involved in the pathogenesis of uterine fibroids and provide a platform for the formulation and testing of new, more specifically targeted hypotheses regarding their biology.
Materials and methods
Tumour materials
In all, 165 fibroid specimens and corresponding normal myometrium from 51 anonymous and unselected Finnish patients were collected at The Helsinki University Central Hospital with the approval of the hospital ethics review committee. The samples were snap frozen in liquid nitrogen and then stored at À801C. Frozen section slides from the tumours for microarray experiment were HE stained and the diagnosis was confirmed. DNA extractions were performed with standard procedures. For the microarrays, at least 30 mg of total RNA were extracted from each sample with the Trizol s reagent (Gibco BRL, Life Technologies Inc., Gaithersburg, MD, USA) and an RNA clean-up with RNeasy s mini columns (Qiagen Ltd, West Sussex, UK) was performed according to the manufacture's instructions. An aliquot was subjected to RNA 6000 Nano Chip (Agilent Tecnologies, Waldbronn, Germany) analysis to verify RNA integrity.
Analysis of LOH
A total of 25 microsatellite markers on chromosome 7q were used to study LOH in all 165 sporadic tumours (Supplementary Table 4 ). Fluorescence-labelled primers (Sigma-Genosys, Cambridgehire, UK) were used to amplify matching normal and tumour DNA with PCR. The PCR products were detected with ABI377 sequencer and analysed with Genotyper 2.5.2 7q deletion mapping and expression profiling in fibroids S Vanharanta et al software (Applied Biosystems, Foster City, CA, USA). LOH was scored by calculating the intensity ratio of the constitutional alleles as described before (Canzian et al., 1996) . Intensity ratio Lo0.60 or L>1.67 was called LOH, 0.60oLo0.75 or 1.33oLo1.67 was called marginal LOH and 0.75oLo1.33 was called normal heterozygosity.
Array-CGH analysis
The array construction and hybridization were performed as described (Fiegler et al., 2003; Douglas et al., 2004) . In brief, the array was prepared from DOP-PCR amplified DNA from 3452 large insert genomic clones at an average spacing of about 1 Mb throughout the genome. DNA from each of the fibroids was labelled with Cy5-dCTP. DNA from a pool of normal individuals was used as a control and labelled with Cy3-dCTP. The test and normal DNAs were cohybridized to the arrays together with herring sperm and CotI DNA and washed. The array was scanned using a confocal scanner (Perkin Elmer) and Spot (Jain et al., 2002) software was used to process the images. After rejecting poorly hybridized arrays by visual inspection of scans and correcting for background, the log 2 ratio of the fluorescence intensities of test (tumour, T) to reference (normal, N) was calculated, after normalization to the remainder of the genome in that tumour. Standard deviations of these ratios were calculated genome-wide. log 2 T:N ratios of >3 were taken to indicate gain and ratios of oÀ3 were scored as loss. Copy number changes of the sex chromosomes were not analysed.
Synthesis of cDNA and biotin-labelled cRNA
The method for synthesising double-stranded cDNA has been described previously (Mahadevappa and Warrington, 1999) . In all, 8 mg of RNA were reverse-transcribed to cDNAs using SuperScriptt Double-Stranded cDNA Syntehesis Kit (Invitrogen, Life Technologies, Carlsbad, CA, USA) and T7-(dT)24 primers (5 0 -GGCCAGTGAATTGTAATACGACTCACTA TAGGGAGGCGG-(dT)24-3 0 , 100 pmol/ml) in a reaction volume of 20 ml according to the method suggested by the manufacturer, except that the incubation temperature was 421C. The second-strand cDNAs were then synthesized in a total volume of 150 ml, also according to the manufacturer's protocol, and were purified using Phase Lock Gelt Heavy 1.5 ml tubes (Eppendorf AG, Hamburg, Germany) and phenol:chloroform premixed with isoamyl alchohol (Amresco, Solon, OH, USA) followed by ethanol precipitation according to the instructions in Affymetrix GeneChip & Expression Analysis Technical Manual (Affymetrix Inc., Santa Clara, CA, USA). BioArrayt HighYieldt RNA Transcript Labeling Kit (Enzo Diagnostics Inc, Farmingdale, NY, USA) was used to synthesize biotin-labelled cRNA from the purified doublestranded cDNA according to the manufacturer's instructions. The labelled cRNA was then purified with RNeasy s mini columns (Qiagen Ltd).
Fragmentation, array hybridization, and scanning
Labelled cRNA was fragmented by incubation at 941C for 35 min in the presence of 40 mM Tris-acetate, pH 8.1, 100 mM potassium acetate, and 30 mM magnesium acetate. The hybridization solution consisted of 15 mg fragmented cRNA and 0.1 mg/mL herring sperm DNA in MES buffer (containing 100 mM MES, 1 M Na þ , 20 mM EDTA, and 0.01% Tween 20). The samples were hybridized on GeneChip s HG-U133A oligonucleotide chips (Affymetrix) at 451C for 16 h. Subsequent washing and staining of the arrays were carried out with Fluidics Station 450 (Affymetrix) as outlined in the Gene-
Chip
s Expression Technical Manual on GeneChip s probe arrays (Affymetrix). The probe arrays were scanned (multiple image scan) using the GeneChip s System GA2500 Scanner (Affymetrix).
Expression data analysis
MAS 5.0 software (Affymetrix) was used to analyse the scanned image and to obtain quantitative information, and the detection calls were determined using cutoff values a 1 ¼ 0.05 and a 2 ¼ 0.065. Subsequently, the data were loaded into dChip 1.3 (Li and Wong, 2001) where it was normalized using the array with mean intensity as the base line. Small values were truncated to 1 and PM/MM difference model was used to check for single, probe and array outliers. Image spikes were treated as outliers as well. Then the expression values of all genes called marginal or present at least in 50% of the samples were imported to Cluster (Eisen et al., 1998) , where the data were log 2 transformed and arrays were centred to the median.
For unsupervised clustering, gene vectors with s.d. o0.6 were filtered out resulting in a list of 1057 genes that were the most differentially expressed across the samples. Subsequently, the arrays were organized with self-organizing maps, and hierarchically clustered using Pearson's correlation coefficient as the similarity metric. The cluster tree image was created with TreeView 1.60 software (Eisen et al., 1998) . Differentially expressed genes were detected using Significance Analysis of Microarrays (SAM) software (Tusher et al., 2001) . In all SAM analyses missing values were imputed with K-Nearest Neighbours Imputer (10 neighbours) and a two-class test for unpaired data was used with 5000 permutations. For the myometrium -fibroid comparison, a median false discovery rate of o5% was obtained with delta-value 0.8 and fold change X1.5. To analyse differentially expressed genes in biologically significant subgroups, functional group enrichment analysis was performed with GoMiner (Zeeberg et al., 2003) . GoMiner uses the two-sided Fisher's exact test to calculate P-values for GO categories (Ashburner et al., 2000) .
Quantitative real-time PCR
The relative DAPK1, RARRES3, and RINT-1 expression levels were determined by quantitative real-time PCR. TATAbox binding protein (TBP) was used as an endogenous control as its expression did not vary significantly between fibroids and myometrium in microarray analysis. cDNA was synthesized from total-RNA using M-MLV reverse transcriptase (Promega, Madison, WI, USA) in the manufacturer's buffer containing 1 mmol/l of dNTP, 40 U of RNase inhibitor (Promega), and 300 ng of random hexamer primers. The reactions took place at 421C for 50 min, followed by 951C for 10 min and 41C for 5 min. The cDNA was amplified in an ABI PRISM SDS5700 sequencing detector system (Applied Biosystems) using TaqMan s Gene Expression Assays (Applied Biosystems) for all genes according to manufacturer's instructions. All reactions were carried out in triplicate. The mean C t value of TBP was subtracted from the mean C t values of DAPK1, RARRES3, and RINT-1 to obtain a dC t value. The dC t values for each sample were scaled to obtain a ddC t value by subtracting the highest dC t value of each gene from all dC t values of the respective gene. Relative expression was calculated using the Equation 2 ÀddCt for DAPK1, RARRES3, and RINT-1. A two-sided heteroscedastic t-test was used two compare the mean DAPK1 and RARRES3 expression of normal myometrium and fibroids, and the mean RINT-1 expression of groups N7Q and 7QD.
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